Taj Pharmaceuticals as Manufacturer of Thiamine Hydrochloride Tablets USP 50mg Thiamine Hydrochloride Tablets USP 50mg manufacturer in India {Taj Pharmaceuticals}; best quality supplier and exporter of Thiamine Hydrochloride Tablets USP 50mg Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Tablets/Tablets/ and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Thiamine Hydrochloride Tablets USP 50mg Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Thiamine Hydrochloride Tablets USP 50mg; primarily of pharmaceuticals preparations known as Thiamine Hydrochloride Tablets USP 50mg; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Thiamine Hydrochloride Tablets USP 50mg for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments. Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Thiamine Hydrochloride Tablets USP 50mg; at Taj Pharma we will appropriately meet diverse needs for Thiamine Hydrochloride Tablets USP 50mg export manufacturing in a wide range of activities from investigation of possible formulations of Thiamine Hydrochloride Tablets USP 50mg, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Thiamine Hydrochloride Tablets USP 50mg through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations